Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F Lant

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Antiviral Therapy|August 1, 1996
Foscarnet-induced changes in plasma concentrations of total and ionized calcium and magnesium in HIV-positive patientsF H Noormohamed, M S Youle, B Tang, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
Pharmacokinetics and absolute bioavailability of oral foscarnet in human immunodeficiency virus-seropositive patientsF H Noormohamed, M S Youle, C J Higgs, et al.
American Journal of Hypertension|February 24, 2001
Relation between sodium-lithium countertransport and hypertriglyceridemia in type V hyperlipidemiaA S Wierzbicki, T C Hardman, J Cheung, et al.
Clinical Pharmacology and Therapeutics|February 1, 1974
Renal action, therapeutic use, and pharmacokinetics of the diuretic bumetanideD L Davies, A F Lant, N R Millard, et al.
British Journal of Pharmacology|March 1, 1973
Some aspects of the clinical pharmacology of bumetanide, a new, potent oral diureticD L Davies, A F Lant, N R Millard, et al.
AIDS Research and Human Retroviruses|August 26, 1999
Pharmacokinetics and hemodynamic effects of single oral doses of thalidomide in asymptomatic human immunodeficiency virus-infected subjectsF H Noormohamed, M S Youle, C J Higgs, et al.
Clinical Science|July 1, 1970
Intestinal absorption of dipeptides and corresponding free amino acids in Hartnup diseaseA M Asatoor, B Cheng, K D Edwards, et al.
Journal of Human Hypertension|September 12, 2000
Effects of lipids in patients with familial hypercholesterolaemia on the kinetics of the sodium-lithium countertransporterA S Wierzbicki, T C Hardman, J Cheung, et al.
Atherosclerosis|November 1, 1993
Cholesterol-lowering drug therapy in a patient with receptor-negative homozygous familial hypercholesterolaemiaM D Feher, J C Webb, D D Patel, et al.
British Journal of Clinical Pharmacology|June 1, 1983
The effect of enalapril on serum prolactinW R McNabb, B A Brooks, F Noormohamed, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Antiviral Therapy|August 1, 1996
Foscarnet-induced changes in plasma concentrations of total and ionized calcium and magnesium in HIV-positive patientsF H Noormohamed, M S Youle, B Tang, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
Pharmacokinetics and absolute bioavailability of oral foscarnet in human immunodeficiency virus-seropositive patientsF H Noormohamed, M S Youle, C J Higgs, et al.
American Journal of Hypertension|February 24, 2001
Relation between sodium-lithium countertransport and hypertriglyceridemia in type V hyperlipidemiaA S Wierzbicki, T C Hardman, J Cheung, et al.
Clinical Pharmacology and Therapeutics|February 1, 1974
Renal action, therapeutic use, and pharmacokinetics of the diuretic bumetanideD L Davies, A F Lant, N R Millard, et al.
British Journal of Pharmacology|March 1, 1973
Some aspects of the clinical pharmacology of bumetanide, a new, potent oral diureticD L Davies, A F Lant, N R Millard, et al.
AIDS Research and Human Retroviruses|August 26, 1999
Pharmacokinetics and hemodynamic effects of single oral doses of thalidomide in asymptomatic human immunodeficiency virus-infected subjectsF H Noormohamed, M S Youle, C J Higgs, et al.
Clinical Science|July 1, 1970
Intestinal absorption of dipeptides and corresponding free amino acids in Hartnup diseaseA M Asatoor, B Cheng, K D Edwards, et al.
Journal of Human Hypertension|September 12, 2000
Effects of lipids in patients with familial hypercholesterolaemia on the kinetics of the sodium-lithium countertransporterA S Wierzbicki, T C Hardman, J Cheung, et al.
Atherosclerosis|November 1, 1993
Cholesterol-lowering drug therapy in a patient with receptor-negative homozygous familial hypercholesterolaemiaM D Feher, J C Webb, D D Patel, et al.
British Journal of Clinical Pharmacology|June 1, 1983
The effect of enalapril on serum prolactinW R McNabb, B A Brooks, F Noormohamed, et al.
Pageof 9